The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of eosinophila with efficacy in non-melanoma patients treated with programmed death 1 inhibitors.
 
Matthew R. Zibelman
Research Funding - Horizon Pharma
Patents, Royalties, Other Intellectual Property - Horizon Pharma (Inst)
 
Julia Judd
No Relationships to Disclose
 
Elizabeth Handorf
Research Funding - Pfizer (Inst)
 
John O'Neill
No Relationships to Disclose
 
Sasini Bentota
No Relationships to Disclose
 
Jamie Doyle
No Relationships to Disclose
 
Robert G. Uzzo
Honoraria - Johnson & Johnson
Consulting or Advisory Role - Myriad Genetics
Speakers' Bureau - Janssen Oncology
 
Jessica Ruth Bauman
No Relationships to Disclose
 
Hossein Borghaei
Honoraria - Bristol-Myers Squibb; Celgene
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Clovis Oncology; Genentech; Lilly
Research Funding - Millennium (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene; Clovis Oncology; Genentech; Lilly
 
Elizabeth R. Plimack
Consulting or Advisory Role - Acceleron Pharma; Bristol-Myers Squibb; Dendreon; Genentech/Roche; GlaxoSmithKline; Merck; Novartis; Pfizer
Research Funding - Acceleron Pharma (Inst); Acerta Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - U.S. Patent No.: 14/588,503, Filed 1/2/2015. (Inst)
 
Ranee Mehra
Employment - GlaxoSmithKline (I)
Stock and Other Ownership Interests - GlaxoSmithKline (I)
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Genentech; Novartis
Research Funding - Genentech
Travel, Accommodations, Expenses - Mirati Therapeutics
 
Daniel M. Geynisman
Consulting or Advisory Role - Novartis; Pfizer; Prometheus
Research Funding - Pfizer
Travel, Accommodations, Expenses - Novartis; Pfizer; Prometheus